Education
About Us
Working with TipRanks
Follow Us
Pfizer (PFE)
NYSE:PFE
Total Valuation
Pfizer has a market cap or net worth of $122.45B. The enterprise value is $198.11B.
Market Cap$122.45B
Enterprise Value$198.11B
Share Statistics
Pfizer has 5.67B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5.67B
Owened by Insiders0.03%
Owened by Instutions12.19%
Financial Efficiency
Pfizer’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.45%.
Return on Equity (ROE)9.11%
Return on Assets (ROA)3.76%
Return on Invested Capital (ROIC)8.45%
Return on Capital Employed (ROCE)8.77%
Revenue Per Employee$785,518.519
Profits Per Employee$98,938.272
Employee Count81,000
Asset Turnover0.30
Inventory Turnover1.51
Valuation Ratios
The current PE Ratio of Pfizer is 18.71. Pfizer’s PEG ratio is 0.07.
PE Ratio18.71
PS Ratio2.36
PB Ratio1.70
Price to Fair Value1.70
Price to FCF15.28
Price to Operating Cash Flow11.79
PEG Ratio0.07
Income Statement
In the last 12 months, Pfizer had revenue of $63.63B and earned $8.01B in profits. Earnings per share was $1.41.
Revenue$63.63B
Gross Profit$41.72B
Operating Income$14.91B
Pretax Income$8.02B
Net Income$8.01B
EBITDA18.13B
Earnings Per Share (EPS)1.41
Cash Flow
In the last 12 months, operating cash flow was $12.74B and capital expenditures -$2.91B, giving a free cash flow of $9.84B billion.
Operating Cash Flow$12.74B
Free Cash Flow$9.84B
Free Cash Flow per Share$1.73
Dividends & Yields
Pfizer pays an annual dividend of $0.43, resulting in a dividend yield of 7.83%
Dividend Per Share$0.43
Dividend Yield7.83%
Payout Ratio54.24%
Free Cash Flow Yield6.55%
Earnings Yield5.34%
Stock Price Statistics
Beta0.25
52-Week Price Change-10.13%
50-Day Moving Average25.43
200-Day Moving Average26.74
Relative Strength Index (RSI)33.44
Average Volume (3m)60.66M
Important Dates
Pfizer upcoming earnings date is Apr 29, 2025, Before Open.
Last Earnings DateFeb 4, 2025
Next Earnings DateApr 29, 2025
Ex-Dividend DateJan 24, 2025
Financial Position
Pfizer as a current ratio of 1.17, with Debt / Equity ratio of 0.72
Current Ratio1.17
Quick Ratio0.92
Debt to Market Cap0.42
Net Debt to EBITDA3.45
Interest Coverage Ratio4.83
Taxes
In the past 12 months, Pfizer has paid -$28.00M in taxes.
Income Tax-$28.00M
Effective Tax Rate-0.35%
Enterprise Valuation
Pfizer EV to EBITDA ratio is 11.74, with an EV/FCF ratio of 21.64.
EV to Sales3.35
EV to EBITDA11.74
EV to Free Cash Flow21.64
EV to Operating Cash Flow16.70
Balance Sheet
Pfizer has $20.48B in cash and marketable securities with $63.65B in debt, giving a net cash position of $43.17B billion.
Cash & Marketable Securities$20.48B
Total Debt$63.65B
Net Cash$43.17B
Net Cash Per Share$7.61
Tangible Book Value Per Share-$6.26
Margins
Gross margin is 74.19%, with operating margin of 23.48%, and net profit margin of 12.62%.
Gross Margin74.19%
Operating Margin23.48%
Pretax Margin12.61%
Net Profit Margin12.62%
EBITDA Margin28.49%
EBIT Margin17.47%
Analyst Forecast
The average price target for Pfizer is $29.23, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$29.23
Price Target Upside33.41%
Analyst ConsensusModerate Buy
Analyst Count15
Revenue Growth Forecast8.77%
EPS Growth Forecast272.80%